Trials / Completed
CompletedNCT02257216
Vayarin® Medical Food Study for Adults With Attention Deficit Hyperactivity Disorder (ADHD)
A Randomized, Sequential Parallel, Double-Blind, Placebo- Controlled Medical Food Study for the Safety and Efficacy of Vayarin® in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 171 (actual)
- Sponsor
- Enzymotec · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
The primary study objective is to evaluate the efficacy of Vayarin in ADHD adults.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Vayarin® | Medical Food |
| OTHER | Placebo | Cellulose |
Timeline
- Start date
- 2014-10-01
- Primary completion
- 2017-05-01
- Completion
- 2017-06-01
- First posted
- 2014-10-06
- Last updated
- 2018-04-11
Locations
4 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02257216. Inclusion in this directory is not an endorsement.